Russell Investments Group Ltd. boosted its position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 41.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,172 shares of the financial services provider’s stock after purchasing an additional 2,706 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trupanion were worth $442,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp increased its stake in shares of Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after buying an additional 238 shares during the period. GAMMA Investing LLC increased its position in shares of Trupanion by 18.5% during the 4th quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after purchasing an additional 267 shares during the last quarter. SBI Securities Co. Ltd. bought a new stake in shares of Trupanion in the fourth quarter valued at $25,000. Swiss National Bank boosted its holdings in shares of Trupanion by 1.1% in the fourth quarter. Swiss National Bank now owns 66,310 shares of the financial services provider’s stock worth $3,196,000 after acquiring an additional 700 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of Trupanion by 2.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock valued at $1,189,000 after purchasing an additional 738 shares in the last quarter.
Trupanion Trading Up 2.0 %
Shares of Trupanion stock opened at $35.68 on Thursday. The business has a 50-day moving average price of $35.90 and a 200-day moving average price of $45.38. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of -155.13, a PEG ratio of 6.02 and a beta of 1.66.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $46.60.
Get Our Latest Stock Report on TRUP
Insider Transactions at Trupanion
In other news, CEO Margaret Tooth sold 4,000 shares of the company’s stock in a transaction on Monday, April 21st. The shares were sold at an average price of $33.34, for a total value of $133,360.00. Following the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,960,258.56. This represents a 3.26 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 1,373 shares of the company’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. This represents a 36.24 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 33,792 shares of company stock valued at $1,122,802. Corporate insiders own 5.50% of the company’s stock.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- 3 Stocks to Consider Buying in October
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- How to Profit From Value Investing
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- How to Buy Cheap Stocks Step by Step
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.